PTC Therapeutics, Inc. engages in the discovery, development, and commercialization of orally administered, small molecule therapeutics targeting an area of RNA biology. Its preclinical and discovery programs are focused on the development of new treatments for multiple therapeutic areas, including neuromuscular disease, oncology and infectious disease. It product, candidate ataluren, is used for the treatment of patients with genetic disorders that arise from a type of genetic mutation known as a nonsense mutation. The company was founded by Allan S. Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
Market Cap | 2.258 Billion | Shares Outstanding | 71.362 Million | Avg 30-day Volume | 620.916 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.89 |
Price to Revenue | 5.2111 | Debt to Equity | 300.0236 | EBITDA | -361.037 Million |
Price to Book Value | 1951.7917 | Operating Margin | -69.52239999999999 | Enterprise Value | 2.465 Billion |
Current Ratio | 1.874 | EPS Growth | -0.119 | Quick Ratio | 1.735 |
1 Yr BETA | 1.0419 | 52-week High/Low | 45.8 / 30.03 | Profit Margin | -97.2722 |
Operating Cash Flow Growth | -29.5052 | Altman Z-Score | -0.8286 | Free Cash Flow to Firm | -234.129 Million |
Earnings Report | 2022-07-28 |
Please sign in first
none
12 Thousand total shares from 6 transactions
2.3 Thousand total shares from 2 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
PAUWELS ERIC CHIEF BUSINESS OFFICER |
|
49,772 | 2022-04-19 | 5 |
KLEIN MATTHEW B. CHIEF OPERATING OFFICER |
|
56,564 | 2022-04-19 | 2 |
PELTZ STUART WALTER CHIEF EXECUTIVE OFFICER |
|
38,646 | 2022-04-14 | 6 |
BOULDING MARK ELLIOTT EXEC. VP AND CLO |
|
420,210 | 2022-04-13 | 7 |
HILL EMILY LUISA CHIEF FINANCIAL OFFICER |
|
29,259 | 2022-03-31 | 5 |
ALMSTEAD NEIL GREGORY CHIEF TECHNICAL OPS OFFICER |
|
51,273 | 2022-02-01 | 4 |
UTTER CHRISTINE MARIE SVP, FINANCE & CAO |
|
25,405 | 2022-02-01 | 3 |
|
18,500 | 2022-01-07 | 1 | |
|
18,500 | 2022-01-07 | 1 | |
|
133,766 | 2022-01-07 | 1 | |
|
18,500 | 2022-01-07 | 1 | |
|
41,755 | 2022-01-07 | 2 | |
|
20,348 | 2022-01-07 | 1 | |
|
19,528 | 2022-01-07 | 1 | |
|
16,163 | 2022-01-07 | 2 | |
|
17,813 | 2022-01-07 | 3 | |
SOUZA MARCIO CHIEF OPERATING OFFICER |
|
6,744 | 2020-02-10 | 0 |
ROTHERA MARK CHIEF COMMERCIAL OFFICER |
|
42,955 | 2017-05-24 | 0 |
KOVACS SHANE WILLIAM CHARLES CHIEF FINANCIAL OFFICER |
|
37,850 | 2017-05-09 | 0 |
|
No longer subject to file | 2017-04-28 | 0 | |
|
0 | 2017-01-03 | 0 | |
|
0 | 2017-01-03 | 0 | |
|
0 | 2017-01-03 | 0 | |
ONG TUYEN CHIEF MEDICAL OFFICER |
|
6,000 | 2017-01-03 | 0 |
SPIEGEL ROBERT J. CHIEF MEDICAL OFFICER |
|
0 | 2016-01-04 | 0 |
|
No longer subject to file | 2015-06-08 | 0 | |
|
2,242 | 2015-03-16 | 0 | |
HIRAWAT CLAUDIA DE OLIVEIRA RIBEIRO PRESIDENT |
|
No longer subject to file | 2015-01-15 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-04-21 16:02:48 -0400 | 2022-04-19 | S | 822 | $42.52 | d | 49,772 | direct | 0.9809 | -11.1419 | 0.9809 | 2 | -11.1419 | 6 | |||
2022-04-21 16:03:58 -0400 | 2022-04-19 | S | 897 | $42.52 | d | 56,564 | direct | 0.9809 | -11.1419 | 0.9809 | 2 | -11.1419 | 6 | |||
2022-04-15 16:04:01 -0400 | 2022-04-14 | S | 82 | $45.28 | d | 38,646 | indirect | 1.6819 | -6.2135 | 1.6819 | 2 | -7.1245 | 5 | |||
2022-04-15 16:02:15 -0400 | 2022-04-13 | M | 2,276 | $11.23 | d | 0 | direct | yes | ||||||||
2022-04-15 16:02:15 -0400 | 2022-04-13 | S | 2,276 | $45.17 | d | 61,110 | direct | yes | 1.6819 | -6.2135 | 1.6819 | 2 | -7.1245 | 5 | ||
2022-04-15 16:02:15 -0400 | 2022-04-13 | M | 2,276 | $11.23 | a | 63,386 | direct | yes | 1.6819 | -6.2135 | 1.6819 | 2 | -7.1245 | 5 | ||
2022-04-07 16:03:07 -0400 | 2022-04-05 | M | 5 | $11.23 | d | 2,276 | direct | yes | ||||||||
2022-04-07 16:03:07 -0400 | 2022-04-05 | S | 5 | $45.00 | d | 61,110 | direct | yes | -0.28 | -0.0933 | 5.5543 | 4 | -0.28 | 2 | ||
2022-04-07 16:03:07 -0400 | 2022-04-05 | M | 5 | $11.23 | a | 61,115 | direct | yes | -0.28 | -0.0933 | 5.5543 | 4 | -0.28 | 2 | ||
2022-04-01 16:20:06 -0400 | 2022-03-31 | S | 7,910 | $37.78 | d | 29,259 | direct | yes | 0.7619 | -1.3392 | 1.3623 | 3 | -1.3392 | 6 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
PTC THERAPEUTICS INC PTCT | 2022-05-16 16:45:03 UTC | 0.5294 | 0.2906 | 850000 |
PTC THERAPEUTICS INC PTCT | 2022-05-16 16:15:03 UTC | 0.5294 | 0.2906 | 850000 |
PTC THERAPEUTICS INC PTCT | 2022-05-16 15:45:03 UTC | 0.5294 | 0.2906 | 850000 |
PTC THERAPEUTICS INC PTCT | 2022-05-16 15:15:03 UTC | 0.5294 | 0.2906 | 850000 |
PTC THERAPEUTICS INC PTCT | 2022-05-16 14:45:03 UTC | 0.57 | 0.25 | 850000 |
PTC THERAPEUTICS INC PTCT | 2022-05-16 14:15:03 UTC | 0.57 | 0.25 | 850000 |
PTC THERAPEUTICS INC PTCT | 2022-05-16 13:45:04 UTC | 0.57 | 0.25 | 850000 |
PTC THERAPEUTICS INC PTCT | 2022-05-16 13:15:03 UTC | 0.57 | 0.25 | 850000 |
PTC THERAPEUTICS INC PTCT | 2022-05-16 12:45:04 UTC | 0.57 | 0.25 | 850000 |
PTC THERAPEUTICS INC PTCT | 2022-05-13 22:15:03 UTC | 0.57 | 0.25 | 750000 |
PTC THERAPEUTICS INC PTCT | 2022-05-13 21:45:03 UTC | 0.57 | 0.25 | 750000 |
PTC THERAPEUTICS INC PTCT | 2022-05-13 21:15:03 UTC | 0.57 | 0.25 | 750000 |
PTC THERAPEUTICS INC PTCT | 2022-05-13 20:45:03 UTC | 0.57 | 0.25 | 750000 |
PTC THERAPEUTICS INC PTCT | 2022-05-13 20:15:03 UTC | 0.57 | 0.25 | 750000 |
PTC THERAPEUTICS INC PTCT | 2022-05-13 19:45:04 UTC | 0.57 | 0.25 | 750000 |
PTC THERAPEUTICS INC PTCT | 2022-05-13 19:15:03 UTC | 0.57 | 0.25 | 750000 |
PTC THERAPEUTICS INC PTCT | 2022-05-13 18:45:03 UTC | 0.5691 | 0.2509 | 750000 |
PTC THERAPEUTICS INC PTCT | 2022-05-13 18:15:03 UTC | 0.5691 | 0.2509 | 750000 |
PTC THERAPEUTICS INC PTCT | 2022-05-13 17:45:03 UTC | 0.5691 | 0.2509 | 750000 |
PTC THERAPEUTICS INC PTCT | 2022-05-13 17:15:03 UTC | 0.5691 | 0.2509 | 750000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund | PTCT | -491.0 shares, $-23582.73 | 2019-12-31 | N-PORT |
FundVantage Trust- Gotham Enhanced Index Plus Fund | PTCT | -19.0 shares, $-847.59 | 2020-03-31 | N-PORT |
FundVantage Trust- Gotham Master Neutral Fund | PTCT | -143.0 shares, $-6685.25 | 2020-09-30 | N-PORT |
FundVantage Trust- Gotham Index Plus All-Cap Fund | PTCT | -47.0 shares, $-2096.67 | 2020-03-31 | N-PORT |
Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund | PTCT | -13499.0 shares, $-537665.17 | 2021-12-31 | N-PORT |
FundVantage Trust- Gotham Hedged Plus Fund | PTCT | -593.0 shares, $-23619.19 | 2021-12-31 | N-PORT |
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | PTCT | -3500.0 shares, $-139405.0 | 2021-12-31 | N-PORT |
AQR Funds- AQR Diversified Arbitrage Fund | PTCT | -20817.0 shares, $-829141.11 | 2021-12-31 | N-PORT |